Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07149025 · ClinicalTrials.gov registry record · NA
OMT & Intractable Singultus
A NA study, sponsored by Michigan State University.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT07149025 is a NA study that has completed, run by Michigan State University. The registered enrollment target is 5 participants.
The verdict
NCT07149025, a NA study, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study plans to use the effects osteopathic manipulative medicine (OMM) techniques to aid in treatment of patients with symptoms of, somatic dysfunction related to, and/or a diagnosis of Intractable Singultus. The aim of our study is to document any changes in associated symptoms of Intractable Singultus before and after osteopathic manipulative treatment (OMT).
Interventions
- PROCEDURE Osteopathic Manipulative Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2025-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07149025
The ClinicalTrials.gov registry entry for NCT07149025 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Osteopathic Manipulative Therapy is the first listed.
NCT07149025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07149025 about?
NCT07149025 is a clinical study titled "OMT & Intractable Singultus". This study plans to use the effects osteopathic manipulative medicine (OMM) techniques to aid in treatment of patients with symptoms of, somatic dysfunction related to, and/or a diagnosis of Intractable Singultus. The aim of our study is to document any changes in associated symptoms of Intractable ...
What is the current status of trial NCT07149025?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2023-05-01. Estimated completion is 2025-02-28.
What interventions are being tested in trial NCT07149025?
The interventions under investigation include: Osteopathic Manipulative Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT07149025?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.